´ëÇѰǼ±ÇÐȸ Á¦6ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2021-04-10±³À°ÀÏÀÚ : 2021-04-10
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ¶óº¥´õ·ë
±³À°ÁÖÁ¦ :
´ëÇѰǼ±ÇÐȸ Á¦6ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѰǼ±ÇÐȸ
´ã´çÀÚ : ±èµ¿Çö
¿¬¶ôó : 031-780-5243
À̸ÞÀÏ :
terios92@cha.ac.kr ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 13:30~13:50 Insufficient response to biologics ±èº´¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 13:50~14:10 Erythrodermic psoriasis Á¤±âÇå(°æÈñÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 14:10~14:30 Eczema-concomitant psoriasis ±èµ¿Çö(Â÷ÀÇ°úÇдë)
Åä·Ð 04¿ù 10ÀÏ ¶óº¥´õ·ë 14:30~14:40 Q&A ±èº´¼ö,Á¤±âÇå,±èµ¿Çö()
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 14:40~15:00 What''s new? IL-17 inhibitors ¹æöȯ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 15:00~15:20 What''s new? IL-23 inhibitors ±èűÕ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 15:20~15:40 What''s new? Apremilast, Dimethyl Fumarate ½ÅºÀ¼®(Á¶¼±ÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ¶óº¥´õ·ë 15:40~15:50 Q&A ¹æöȯ,±èűÕ,½ÅºÀ¼®()
ÈÞ½Ä 04¿ù 10ÀÏ ¶óº¥´õ·ë 15:50~16:15 ()
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 16:15~16:35 »ý¹°ÇÐÀûÁ¦Á¦ ½ºÀ§Äª, ÀçÅõ¿© Á¶¼ºÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¶óº¥´õ·ë 16:35~16:55 »êÁ¤Æ¯·Ê ½ÃÀÛ, ¿¬Àå ¹ÚÇýÁø(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ¶óº¥´õ·ë 16:55~17:15 Q&A Á¶¼ºÁø,¹ÚÇýÁø()